Login
Astrazeneca PLC (ADR) NYSE: AZN
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company.
| Name | Astrazeneca PLC (ADR) |
| Ticker | AZN |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Price | 54.17 |
| 52W Low/High | 37.79 / 61.10 |
| Market cap | 142 B |
| 1Y Total Return |
22.56%
Strong |
| 1Y Volatility |
34.25%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company.
Details
| Ticker | AZN |
| Name | Astrazeneca PLC (ADR) |
| ISIN | |
| CUSIP | 046353108 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Country | Great Britain |
| Currency | U.S. Dollar |
Share as of 9/24/20
| Close Price | 54.17 |
| 52W Low/High | 37.79 / 61.10 |
| Market cap | 142 B |
| 1Y Total Return |
22.56%
Strong |
| 1Y Volatility |
34.25%
Low Risk |
| Beta | 0.45 |
| PE (trailing) |
66.47
High |
| 12M Dividends | 1.4 |
| Last Dividend Date | 8/13/20 |
| Dividend Yield | 2.58% |
Fin. Strength
| Net Profit Margin | 8.0% |
| Cash from Op. / Cur. Liabilities | 0.27 |
| Diluted Earnings / Share | 0.82 |
| ROE | 15.9% |
| ROIC | 7.8% |
| Price / Revenue | 2.8 |
| Price / Book | 5.8 |
| Price / CF | 14.6 |
| Current Ratio | 0.8 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 1.61 |
| in Mils USD |
rolling-year up to June
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
25,699
|
23,071
|
22,342
|
21,740
|
24,062
|
25,589
|
|
| Gross Profit |
20,566
|
18,089
|
17,722
|
17,836
|
19,686
|
20,171
|
|
| R&D |
6,214
|
5,913
|
5,596
|
5,747
|
6,120
|
5,873
|
|
| EBITDA |
7,672
|
7,288
|
6,413
|
7,795
|
6,483
|
5,394
|
|
| Operating Income |
3,838
|
3,518
|
3,294
|
5,403
|
3,599
|
2,048
|
|
| Net Income exc. Extra |
2,045
|
2,085
|
2,545
|
3,770
|
2,172
|
1,180
|
|
| per Share | |||||||
| Diluted avg Shares |
1,313
|
1,312
|
1,267
|
1,267
|
1,265
|
1,265
|
|
| EPS exc. Extra |
0.82
|
0.86
|
1.06
|
1.53
|
0.88
|
0.47
|
|
| Dividend |
1.40
|
1.40
|
1.40
|
1.40
|
1.40
|
2.80
|
|
| Div. Yield (an.) |
2.65%
|
3.39%
|
3.99%
|
4.11%
|
4.64%
|
8.30%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
59,929
|
61,889
|
61,344
|
65,119
|
64,369
|
55,169
|
|
| Cash, Eq & Invt ShortTerm |
6,115
|
6,247
|
3,777
|
6,237
|
4,646
|
4,498
|
|
| Total Current Assets |
14,930
|
15,219
|
12,449
|
14,298
|
13,335
|
13,812
|
|
| Total Non-Current Assets |
44,999
|
46,670
|
48,895
|
50,821
|
51,034
|
41,357
|
|
| Intangibles |
31,373
|
33,925
|
36,604
|
39,239
|
41,221
|
31,953
|
|
| Total Liabilities |
46,271
|
46,818
|
47,072
|
49,707
|
48,979
|
36,870
|
|
| Total Current Liabilities |
18,183
|
16,034
|
17,201
|
15,657
|
14,335
|
16,150
|
|
| Long Term Debt |
28,088
|
30,784
|
29,871
|
34,050
|
34,644
|
20,720
|
|
| Shareholder equity |
12,237
|
13,548
|
12,645
|
13,653
|
13,530
|
18,279
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
4,861
|
3,831
|
4,730
|
5,234
|
5,174
|
8,792
|
|
| Depreciation |
3,762
|
3,753
|
3,036
|
2,357
|
2,852
|
3,282
|
|
| Cash from Investing |
-657
|
963
|
-2,328
|
-3,969
|
-4,239
|
-7,032
|
|
| Capex |
942
|
1,031
|
1,243
|
1,364
|
1,281
|
854
|
|
| Cash from Financing |
-1,765
|
-2,044
|
-2,936
|
-1,324
|
878
|
-2,705
|
|
| Stock Issued |
3,525
|
34
|
43
|
47
|
43
|
279
|
|
| Debt (LT) Issued |
-1,702
|
1,473
|
560
|
2,172
|
4,372
|
653
|
|
| Free Cash Flow |
7,165
|
4,358
|
6,908
|
8,290
|
3,333
|
6,919
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
8.0%
|
9.0%
|
11.4%
|
17.3%
|
9.0%
|
4.6%
|
|
| NCFO / Op.Income |
126.7%
|
108.9%
|
143.6%
|
96.9%
|
143.8%
|
429.3%
|
|
| Current Ratio |
0.8
|
0.9
|
0.7
|
0.9
|
0.9
|
0.9
|
|
| Financial Leverage D/E |
1.61
|
1.45
|
1.56
|
1.44
|
1.30
|
0.60
|
|
| Return on Capital Avg |
7.8%
|
8.6%
|
9.1%
|
11.2%
|
6.8%
|
6.1%
|
|
| Return on Shareholder Equity |
15.9%
|
15.9%
|
19.4%
|
27.7%
|
13.7%
|
5.9%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available